Editors: Editorial Board

The views & opinions expressed are those of the contributing authors and editors and do not necessarily represent the views of the ACC. More

  • Case Challenge

    Following TAVR, what is the optimal antithrombotic strategy for a 68-year-old male patient who presented with shortness of breath and a recent episode of loss of consciousness with exertion?

    More
  • Article of the Month

    Dr. Anna Plitt reviews a comparative study of bridging therapy with heparin vs. continued warfarin therapy without a bridge in patients with moderate-to-high risk of thromboembolic events.

    More
  • Video

    Drs. Peter Block and Nikolaus Sarafoff discuss this trial comparing six weeks vs. six months clopidogrel in DES patients receiving triple therapy.

    More
  • Hot Topic

    Dr. Dylan Steen evaluates the most clinically relevant updates to the atrial fibrillation guidelines.

    More
  • Community

    Visit this community to learn more about and discuss topics related to the entire class of novel oral anticoagulants.

    More
  • Resource

    As a member of The Evolution of Anticoagulation Management – Atrial Fibrillation (TEAM-A) partnership, the ACC is pleased to share access to valuable resources.

    More

advertisement

SITE SPONSORED BY

advertisement